Correlation Between Orexo AB and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both Orexo AB and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orexo AB and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orexo AB and Neurocrine Biosciences, you can compare the effects of market volatilities on Orexo AB and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orexo AB with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orexo AB and Neurocrine Biosciences.
Diversification Opportunities for Orexo AB and Neurocrine Biosciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Orexo and Neurocrine is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Orexo AB and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Orexo AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orexo AB are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Orexo AB i.e., Orexo AB and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between Orexo AB and Neurocrine Biosciences
If you would invest 108.00 in Orexo AB on December 30, 2024 and sell it today you would earn a total of 0.00 from holding Orexo AB or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Orexo AB vs. Neurocrine Biosciences
Performance |
Timeline |
Orexo AB |
Neurocrine Biosciences |
Orexo AB and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Orexo AB and Neurocrine Biosciences
The main advantage of trading using opposite Orexo AB and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orexo AB position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.Orexo AB vs. Hypera SA | Orexo AB vs. Elanco Animal Health | Orexo AB vs. SIGA Technologies | Orexo AB vs. Esperion Therapeutics |
Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |